Enochian Biosciences, Inc. carries a market capitalization of 45.38M, placing it among publicly traded companies globally.
| Market Cap | 45.38M |
| Enterprise Value | N/A |
Enochian Biosciences, Inc.'s stock has declined approximately -66.86047% over the past 52 weeks. The 50-day moving average sits at 0.65, while the 200-day moving average is 1.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -66.86047% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 1.14 |
| Average Volume (20 Days) | N/A |